Antiblastic chemotherapy drugs up-modulate interferon-gamma receptor expression on human malignant T cells

Cancer Detect Prev. 1997;21(2):191-5.

Abstract

We have previously shown that the contrasting ability of interferon-gamma (IFN-gamma) either to stimulate the proliferation of malignant T cells or to induce their apoptosis is determined by the low and high intensity of IFN-gamma receptor (IFN-gamma R) expression, respectively. High IFN-gamma R expression is a marker for the T cell stress that precedes apoptosis. In this paper, we show that a 12- to 24-h culture of three human malignant T-cell lines displaying distinct differentiation stages (ST4, PF382, and Jurkat) in medium supplemented with four chemotherapy drugs (etoposide, cisplatin, cytarabine, and daunomycin) up-modulates their IFN-gamma R expression followed by their apoptosis after 24-48 h later. Increased IFN-gamma R expression (by at least an order of magnitude) was observed in 30 to 90% of cells during exposure to pharmacologic drug concentrations. Timely combination of chemotherapy drugs with IFN-gamma may thus provide a more effective way of inhibiting the progress of human malignant T cells through synergistic induction of their apoptosis.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Apoptosis / drug effects
  • Cell Division / drug effects
  • Cisplatin / pharmacology
  • Cytarabine / pharmacology
  • Daunorubicin / pharmacology
  • Etoposide / pharmacology
  • Flow Cytometry
  • Interferon gamma Receptor
  • Leukemia-Lymphoma, Adult T-Cell / pathology*
  • Lymphoma, T-Cell / pathology*
  • Neoplastic Stem Cells / drug effects*
  • Neoplastic Stem Cells / metabolism
  • Receptors, Interferon / biosynthesis*
  • Receptors, Interferon / genetics
  • T-Lymphocytes / drug effects*
  • T-Lymphocytes / metabolism
  • Tumor Cells, Cultured
  • Up-Regulation / drug effects*

Substances

  • Antineoplastic Agents
  • Receptors, Interferon
  • Cytarabine
  • Etoposide
  • Cisplatin
  • Daunorubicin